Technical Comparison
Spyre Therapeutics, Inc. - Common Stock vs NVIDIA Corporation - Common Stock
Real-time financial comparison matrix between SYRE and NVDA.
Primary Asset
SYR
Spyre Therapeutics, Inc. - Common Stock
Market Rank #1004693Live Price$99.05
Market Capitalization$9.3B
24h Change+6.60%
Circulating Supply93M SYRE
Comparison Asset
NVD
NVIDIA Corporation - Common Stock
Market Rank #101Live Price$217.94
Market Capitalization$5.3T
24h Change+0.90%
Circulating Supply24B NVDA
Market Metric Matrix
| Comparison Metric | SYRE Value | NVDA Value | Dominant Asset |
|---|---|---|---|
| Market Cap Rank | #1004693 | #101 | NVIDIA Corporation - Common Stock |
| Unit Price Valuation | $99.05 | $217.94 | NVIDIA Corporation - Common Stock |
| Total Liquid Cap | $9.3B | $5.3T | NVIDIA Corporation - Common Stock |
Frequently Asked Questions
Is Spyre Therapeutics, Inc. - Common Stock bigger than NVIDIA Corporation - Common Stock?
Spyre Therapeutics, Inc. - Common Stock has a market cap of $9.3B, while NVIDIA Corporation - Common Stock sits at $5.3T. Therefore, NVIDIA Corporation - Common Stock is currently the larger financial asset by market capitalization.
What is the price ratio between Spyre Therapeutics, Inc. - Common Stock and NVIDIA Corporation - Common Stock?
Currently, 1 SYRE is worth 0.45 NVDA.